Retatrutid na-apụta dị ka otu n'ime ọgwụgwọ kachasị ọhụrụ na ngalaba nke ọrịa metabolic, ọkachasị maka oke ibu na ụdị ọrịa shuga 2. N'adịghị ka ọgwụgwọ ọdịnala, Retatrutid na-etinye ike jikọtara ọnụ nke GLP-1, GIP na glucagon agonists iji gbado anya ọtụtụ ụzọ metabolic n'otu oge. Omume ugboro atọ a na-ekwu maka isi ihe na-akpata oke ibu na nguzogide insulin site na imeziwanye mmetụta insulin, na-ebelata agụụ, na ịkwalite metabolism abụba. Ihe na-eme ka Retatrutid dị iche na GLP-1 agonists ndị ọzọ na-anabata ya bụ imepụta mkpụrụ ndụ ya pụrụ iche, nke jikọtara ụzọ atọ a bụ isi nke hormonal, na-eme ka ọ bụrụ ngwá ọrụ dị ike na njikwa ibu na njikwa glucose ọbara.
Retatrutid bụ agonist atọ na-anabata ihe, otu ọgwụ na-arụ ọrụ n'otu oge na-anabata homonụ atọ dị iche iche - GLP-1 (glucagon-like peptide 1), GIP (polypeptide inhibitory gastric), na glucagon. Ọtụtụ ndị na-anabata GLP-1 ọdịnala, dị ka semaglutide ma ọ bụ liraglutide, na-elekwasị anya na GLP-1 naanị. Agbanyeghị, nchikota pụrụ iche nke Retatrutid GLP-1, GIP, na glucagon na-enye ya ikike ime ihe n'ụzọ zuru ezu na metabolism, na-agwa ọtụtụ ihe na-ebute oke ibu na ụdị ọrịa shuga 2.
Nhazi molikula nke Retatrutid na-etinye usoro nlebara anya nnabata nke abụọ: GLP-1 na-eme ka ntọhapụ insulin na-ebelata ma belata ọkwa shuga ọbara, GIP na-akwalite secretion insulin mgbe nri gasịrị, na glucagon na-akwalite abụba ọkụ. Usoro a zuru oke na-enye ohere ka Retatrutid ọ bụghị naanị ijikwa ọkwa glucose kamakwa na-akwado nnukwu oke ibu site na mma oxidation abụba na njikwa agụụ.
Ọrụ Retatrutid dabere n'ikike ya imetụta ọtụtụ ụzọ metabolic n'otu n'otu, nke ọ bụla na-enye aka na mmụba nke mmetụta insulin, njikwa glucose ọbara na njikwa ibu. N'okpuru ebe a bụ nkowa etu o si arụ ọrụ:
GLP-1 bụ homonụ na-achịkwa ọkwa shuga dị n'ọbara site n'ịkwalite mmepụta insulin site na pancreas mgbe o risịrị nri. Ọ na-egbochi mwepụta glucagon, na-egbochi imeju iwepụta glucose karịrị akarị. Retatrutid na-eṅomi omume GLP-1, na-ebelata ọkwa glucose ọbara n'ụzọ dị ukwuu site na ịkwalite ntọhapụ insulin na igbochi glucagon.
Na mgbakwunye na ọrụ ya na nhazi glucose, GLP-1 na-arụkwa ọrụ dị mkpa na njikwa agụụ. Ọ na-ebelata nsị nke afọ, nke na-eme ka ọ dịkwuo ogologo oge nke zuru oke, na-enyere aka belata oriri na-eri nri ma na-akwalite ọnwụ. Nke a na-eme GLP-1 dị ike na-emekọrịta ihe n'ịlụso oke ibu ọgụ.
GIP bụ hormone incretin ọzọ na-akwado mmepụta insulin, karịsịa mgbe nri gasịrị. Site n'ịrụ ọrụ na GLP-1, GIP na-eme ka mmetụta insulin dịkwuo elu, na-ahụ na glucose na-arụ ọrụ nke ọma. Ihe mgbakwunye a na-enyere aka mee ka ọ̀tụ̀tụ̀ shuga dị n'ọbara kwụsịlata ma hụ na a na-ewepụta insulin n'oge kwesịrị ekwesị na nke kwesịrị ekwesị, na-ebelata ohere nke hyperglycemia.
Ọ bụ ezie na naanị GIP enweghị otu mmetụta na-egbochi agụụ dị ka GLP-1, ọ na-akwado ọrụ insulin, na-eme ka nguzozi metabolic zuru oke. Ngwakọta a na-eme ka usoro glucose ọbara dịkwuo mma, na-eme ka ọ bụrụ akụkụ dị mkpa nke usoro Retatrutid.
A maara Glucagon n'ọdịnala maka iweli ọkwa shuga dị n'ọbara site na igosi imeju ka ọ hapụ glucose. Agbanyeghị, n'ihe gbasara Retatrutid, ịgbalite nnabata glucagon na-arụ ọrụ ọhụrụ. Kama ịbawanye ọkwa glucose, glucagon na Retatrutid na-akpali oxidation abụba, na-agba ume nbibi nke abụba echekwara maka ike. Nke a na-eme ka mfu abụba dịkwuo mma ma na-emeziwanye ihe mejupụtara ahụ site na ichekwa oke uru ahụ siri ike.
Omume glucagon, yana GLP-1 na GIP, na-agbanwe metabolism nke anụ ahụ gaa na abụba na-ere ọkụ, na-eme ka Retatrutid dị irè karịsịa maka ndị mmadụ na-alụ ọgụ na oke ibu yana nguzogide insulin.
Retatrutid na-enye uru abụọ: ọ na-arụ ọrụ nke ọma n'ijikwa ma mbelata ibu na njikwa glucose ọbara. Maka ndị ọrịa nwere oke ibu na ọrịa shuga 2dị nke abụọ, akụkụ abụọ a na-ejikọkarị ọnụ, n'ihi na oke ibu na-enye aka na nguzogide insulin ma na-eme ka usoro glucose ọbara dịkwuo njọ. Mgbasa ozi ọtụtụ nnabata nke Retatrutid na-ekwu okwu abụọ n'otu oge.
Retatrutid na-enyere aka na mbelata ibu site na mmetụta ya na-egbochi agụụ na ike ya ịbawanye oxidation abụba. Ngwakọta nke GLP-1, GIP, na glucagon na-ebute mbelata oriri nri, satiety emelitere, yana mmụba nke abụba abụba. Nke a na-eme Retatrutid ka ọ bụrụ ọgwụgwọ na-ekwe nkwa maka oke ibu yana ihe ngwọta dị ogologo oge maka ndị ọrịa na-achọ njikwa ibu na-adigide.
Retatrutid na-eme ka mmetụta insulin dịkwuo elu, na-eme ka ahụ dịkwuo mma na metabolize glucose. Site na ịkwalite mmepụta insulin na igbochi mwepụta glucagon, ọ na-enyere aka mee ka ọ̀tụ̀tụ̀ shuga dị n'ọbara guzosie ike, na-eme ka ọ bụrụ ọgwụgwọ dị irè maka ọrịa shuga 2dị nke Abụọ. Nsonaazụ bụ njikwa glycemic ka mma yana ibelata nguzogide insulin, nke nwere ike ibelata mkpa nchịkwa insulin na-apụ apụ.
Pharmacokinetics na-ezo aka ka otu ọgwụ si etinye, kesaa, metabolized, na nke ahụ, na-enye nghọta dị mkpa banyere otu ọgwụ ahụ si arụ ọrụ na ugboro ole ọ dị mkpa ka a na-enye ya. A na-enye Retatrutid, ọgwụgwọ ọgbọ na-abịa maka oke ibu na ọrịa shuga 2dị nke abụọ, site na ntụtụ subcutaneous, na-enye uru nke ị theụ ọgwụ otu ugboro kwa izu. Usoro a na-eme ogologo oge na-enye ohere ka ọgwụ ahụ nọgide na-adị irè ruo ogologo oge, nke bụ uru dị ukwuu maka ndị ọrịa ma e jiri ya tụnyere ọgwụ ndị ọzọ na-abaghị uru ma ọ bụ ọrịa shuga nke nwere ike ịchọ nlekọta kwa ụbọchị.
Mgbe ịgbanyechara ya, Retatrutid na-abanye n'ọbara, ebe ọ na-emekọrịta ihe na GLP-1, GIP, na ndị na-anabata glucagon iji mezie metabolism metabolism, agụụ na nchekwa abụba. N'otu oge n'ime ọbara, a na-emeju ọgwụ ahụ site na imeju wee si na akụrụ pụta. Ọgwụ ahụ nwere ogologo ndụ ọkara, nke na-enyere ya aka ịnọgide na-enwe usoro ọgwụgwọ maka izu zuru ezu n'etiti doses. Profaịlụ ọgwụ a na-eme Retatrutid ọ bụghị naanị dị irè kamakwa ọ dịkwa mma, na-achọ injections ole na ole ka ọ na-ebuga uru na-adịgide adịgide na njikwa glucose ọbara na njikwa ibu.
Retatrutid na-aga ugbu a nnukwu nnwale ụlọ ọgwụ iji chọpụta nchekwa na ịdị irè ya na-adịte aka, yana ikike ọ nwere maka nkwado FDA. Ọnwụnwa nke mmalite egosilarị nsonaazụ dị mma, ọkachasị n'akụkụ oke ibu na njikwa glycemic. Ọgwụ a egosila na ọ na-arụ ọrụ nke ọma n'ibelata ibu ahụ yana imeziwanye ọkwa HbA1c (ihe nrịbama njikwa shuga ọbara na-adịte aka) na ndị ọrịa nwere ọrịa shuga 2dị nke abụọ na oke ibu. Nsonaazụ ndị a na-egosi na Retatrutid nwere ikike ịbụ ọgwụgwọ nkuku maka ọrịa metabolic.
Emebere Retatrutid n'ụzọ bụ isi maka ndị na-alụ ọgụ maka oke ibu na ụdị ọrịa shuga 2, ọkachasị ndị na-enwebeghị ihe ịga nke ọma na ọgwụgwọ ọdịnala ma ọ bụ mgbanwe ndụ. Ikike ya ileba anya ma mbelata ibu yana nguzogide insulin na-eme ka ọ dabara adaba maka ndị ọrịa nwere ọnọdụ abụọ ahụ n'otu oge. Omume abụọ a dị oke mkpa, n'ihi na oke ibu bụ isi ihe na-akpata ọrịa shuga 2dị nke Abụọ, na ilebara okwu abụọ a anya n'otu oge nwere ike imeziwanye ahụike na ndụ onye ọrịa n'ozuzu ya. Na mgbakwunye, Retatrutid na-ekwe nkwa dị ka ọgwụgwọ maka ọrịa metabolic, ọnọdụ nke oke ibu, ọbara mgbali elu, na nguzogide insulin na-adị, nke na-ebikọkarị na ọrịa shuga 2dị 2.
Ka ule ụlọ ọgwụ na-aga n'ihu na ọgwụ ahụ na-erute nkwado FDA, Retatrutid nwere ikike ịgbanwe ọdịdị nke ọgwụgwọ ọrịa metabolic, na-enye ngwọta zuru oke maka ndị mmadụ na-ata ahụhụ site na ọnọdụ ndị a jikọtara ọnụ.
Retatrutid na-anọchite anya ihe ọhụrụ na-agbawa obi na ọgwụgwọ oke ibu na ụdị ọrịa shuga 2. Site n'ịtụle ọtụtụ ụzọ metabolic - GLP-1, GIP, na glucagon-ọgwụgwọ akwụkwọ akụkọ a na-enye uru abụọ: nnukwu ibu ibu na njikwa glycemic ka mma. Nnwale ụlọ ọgwụ egosila ikike siri ike, nchọpụta na-aga n'ihu na-egosi na Retatrutid nwere ike gbanwee otú anyị si abịaru nso ọrịa metabolic, na-enye olileanya ọhụrụ maka ọtụtụ nde mmadụ ndị na-alụso oke ibu ọgụ, nguzogide insulin na ọrịa shuga 2.
Ka nkwado FDA na-abịaru nso, Retatrutid na-adị njikere ịghọ otu n'ime ọgwụgwọ kachasị dị irè maka ahụike metabolic. Maka ndị nwere mmasị na ngwọta dị mma na ọgwụgwọ peptide, Cocer Peptides Co., Ltd bụ onye mmekọ tụkwasịrị obi na ụlọ ọrụ ahụ, na-enye ngwaahịa kachasị elu na ndụmọdụ ọkachamara banyere otu ọgwụgwọ dabeere na peptide nwere ike isi gbanwee njem ahụike gị. Ma ị na-enyocha usoro ọgwụgwọ ọhụrụ ma ọ bụ na-achọ ndị na-ebubata ntụkwasị obi, Cocer Peptides Co., Ltd. dị njikere ịkwado mkpa gị. Gbalịa mụtakwuo maka ọdịnihu ọgwụgwọ ọrịa metabolic yana otu Cocer Peptides nwere ike isi duzie gị n'ịkwalite ọganihu sayensị kachasị ọhụrụ.